Number of plans Share-Based Compensation Arrangement, Number of Plans Share-Based Compensation Arrangement, Number of Plans Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Reserve for excess or obsolete inventory Inventory Valuation Reserves Research and development Research and Development Expense Issuances Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Class of warrant or right, conversion terms, threshold trading days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Class Of Warrant Or Right, Conversion Terms, Threshold Trading Days Liquidation preference (in dollars per share) Preferred Stock, Liquidation Preference Per Share Award Type [Domain] Award Type [Domain] Issuances Temporary Equity, Stock Issued During Period, Value, New Issues Statement of Stockholders' Equity [Abstract] Guideline Public Company Model Guideline Public Company Model [Member] Guideline Public Company Model Proceeds from transaction Proceeds From Reverse Recapitalization Transaction Proceeds From Reverse Recapitalization Transaction Commercial Milestone, $1,000,000 Annual Sales Commercial Milestone, $1,000,000 Annual Sales [Member] Commercial Milestone, $1,000,000 Annual Sales Nature of Business [Line Items] Nature of Business [Line Items] Nature of Business [Line Items] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Commitments and contingencies Commitments and Contingencies Expected share price volatility Measurement Input, Price Volatility [Member] Payments for repurchase of warrants Payments for Repurchase of Warrants Number of shares issued in transaction, potential increased amount (in shares) Sale of Stock, Number of Shares Issued in Transaction, Potential Increased Amount Sale of Stock, Number of Shares Issued in Transaction, Potential Increased Amount MTAC Warrants MTAC Warrants [Member] MTAC Warrants Purchase agreement, maximum shares allowed, percentage of average daily volume Common Stock, Share Price, Percentage Of Average Daily Volume Common Stock, Share Price, Percentage Of Average Daily Volume Income Taxes Income Tax Disclosure [Text Block] Gain on expired warrants Gain (Loss) on Warrant Expirations Gain (Loss) on Warrant Expirations Leases Lessee, Leases [Policy Text Block] Series B Series B Convertible Preferred Stock [Member] Series B Convertible Preferred Stock Current liabilities: Liabilities, Current [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, Series A, $0.0001 par value per share, $10.00 liquidation value per share. Authorized 10,000,000 and 0 shares at September 30, 2023, and December 31, 2022, respectively; issued and outstanding, 4,015,002 and 0 shares at September 30, 2023, and December 31, 2022, respectively Preferred Stock, Value, Issued Payment for asset acquisition Payments for Asset Acquisition Payments for Asset Acquisition Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Series B-2 Tranche Liability Series B-2 Tranche Liability [Member] Series B-2 Tranche Liability Original issue price (in dollars per share) Preferred Stock, Issued Price Per Share Preferred Stock, Issued Price Per Share Net loss per share, diluted (in dollars per share) Earnings Per Share, Diluted Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Maximum shares of common stock allowed under Purchase Agreement (in shares) Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Standby Equity Purchase Agreement, Maximum Amount Of Shares Authorized Series A-4 Series A-4 Convertible Preferred Stock [Member] Series A-4 Convertible Preferred Stock Exercise of options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Options, weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Net loss available to common stockholders Net loss Net loss available to common stockholders Net Income (Loss) Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Derivative Contract [Domain] Derivative Contract [Domain] Class of warrant or right, redemption price (in dollars per share) Class of Warrant or Right, Redemption Price Class of Warrant or Right, Redemption Price Series A-5 Series A-5 Convertible Preferred Stock [Member] Series A-5 Convertible Preferred Stock Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Liabilities and Stockholders’ Equity (Deficit) Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Cost of goods sold Cost of Goods and Services Sold Percentage of then-outstanding preferred stock on an as-converted to common stock basis Preferred Stock, Conversion, Percentage of Outstanding Shares Preferred Stock, Conversion, Percentage of Outstanding Shares Share-Based Compensation Plan Balances Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Series A Convertible Preferred Stock, floor conversion price (in dollars per share) Preferred Stock, Conversion Price, Floor Preferred Stock, Conversion Price, Floor Tranche Two Derivative Instrument, Period Two [Member] Derivative Instrument, Period Two Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Series A-3 Series A-3 Convertible Preferred Stock [Member] Series A-3 Convertible Preferred Stock Equity Components [Axis] Equity Components [Axis] Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Available for Issue (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Asset Acquisition [Domain] Asset Acquisition [Domain] Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements MedTech Acquisition Corporation MedTech Acquisition Corporation [Member] MedTech Acquisition Corporation Offering costs related to Business Combination Expenses related to business combination Payments Of Reverse Recapitalization, Transaction Costs Payments Of Reverse Recapitalization, Transaction Costs Warrants Warrant [Member] Warrants exercised (in shares) Exercises (in shares) Class of Warrant or Right, Warrants Exercised Class of Warrant or Right, Warrants Exercised Threshold number of business days before sending notice of redemption to warrant holders Class Of Warrant Or Right, Conversion Days Notice Class Of Warrant Or Right, Conversion Days Notice Private Placement Warrants Private Warrants [Member] Private Warrants Restricted stock units Restricted Stock Units (RSUs) [Member] Nature of Business [Table] Nature of Business [Table] Nature of Business [Table] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Sale of stock (in shares) Sale of Stock, Number of Shares Issued in Transaction Payables and Accruals [Abstract] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Convertible preferred stock Convertible preferred stock, beginning balance Convertible preferred stock, ending balance Temporary Equity, Carrying Amount, Attributable to Parent Contingent earnout liability Contingent Earnout Liability [Member] Contingent Earnout Liability Class of warrant or right, conversion terms, threshold consecutive trading days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Class of Warrant or Right, Conversion Terms, Threshold Consecutive Trading Days Inventory Increase (Decrease) in Inventories Series B-1 Series B-1 Convertible Preferred Stock [Member] Series B-1 Convertible Preferred Stock Tranche Two Tranche Two [Member] Tranche Two Award Type [Axis] Award Type [Axis] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Derivative Instruments and Hedging Activities Disclosure [Abstract] RSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Purchase agreement, sales price, percentage of market price during three consecutive trading days Share Price As Percentage Of Market Price With Advance Notice, Option Two Share Price As Percentage Of Market Price With Advance Notice, Option Two Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Interest expense Interest Expense Unrecognized compensation expense, RSUs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Options and RSU's outstanding (in shares) Authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Use of Estimates Use of Estimates, Policy [Policy Text Block] Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Prepaid expenses Prepaid Expense, Current Percentage of fully diluted common stock determined in preceding year Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage of Total Stock Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Percentage of Total Stock Entity Shell Company Entity Shell Company Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Intangible assets, net Finite-Lived Intangible Assets, Net Temporary Equity [Line Items] Temporary Equity [Line Items] Loss on change in fair value Derivative, Loss on Derivative Prepaid expenses Increase (Decrease) in Prepaid Expense Shares unvested (in shares) Derivative Instrument, Contingent Consideration, Liability, Shares Number of Shares Unvested Counterparty Name [Domain] Counterparty Name [Domain] Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Total cash, cash equivalents and restricted cash shown in the Condensed Consolidated Statements of Cash Flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Expected term (years) Measurement Input, Expected Term [Member] Private Placement Private Placement [Member] Sale of stock, price per share (in dollars per share) Sale of Stock, Price Per Share Interest income Investment Income, Interest Royalties as a percentage of net sales, under sales threshold Asset Acquisition, Royalty Percentage, Under Threshold Amount Asset Acquisition, Royalty Percentage, Under Threshold Amount Impairment and Disposal of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Gross profit Gross Profit Convertible preferred stock, par value per share (in dollars per share) Temporary Equity, Par or Stated Value Per Share Security Exchange Name Security Exchange Name Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Net proceeds on sale of stock Sale of Stock, Consideration Received on Transaction Binomial Tranche Model Binomial Tranche Model [Member] Binomial Tranche Model Options to purchase common stock Employee Stock Option [Member] Contingent Earnout Liability Derivative Instruments and Hedging Activities Disclosure [Text Block] Series B-2 Series B-2 Convertible Preferred Stock [Member] Series B-2 Convertible Preferred Stock Asset Acquisition [Table] Asset Acquisition [Table] Maximum Maximum [Member] Document Type Document Type Warrant liability Derivative Financial Instruments, Warrant Liability [Member] Derivative Financial Instruments, Warrant Liability Entity Address, Address Line One Entity Address, Address Line One Inventory Inventory, Policy [Policy Text Block] Exchange ratio Recapitalization Exchange Ratio Recapitalization Exchange Ratio Dynavax Purchase Asset Acquisition [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Derivative liability, current Derivative Liability, Current Share-Based Compensation Share-Based Payment Arrangement [Text Block] Proceeds from MTAC trust account Proceeds from Contributed Capital Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Current stock price Measurement Input, Share Price [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Net Transfer In (Out) of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Number of product lines in development Number of Product Lines in Development Number of Product Lines in Development Subsequent Event Subsequent Event [Member] Restricted cash (included in Other assets) Restricted Cash, Noncurrent Other current liabilities Other Liabilities, Current Conversion ratio Preferred Stock, Convertible, Conversion Ratio Trade payables, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Reverse Recapitalization [Line Items] Reverse Recapitalization [Line Items] Reverse Recapitalization Tranche [Domain] Tranche [Domain] Tranche [Domain] Issuance of preferred stock with PIPE financing (in shares) Issuances (in shares) Stock Issued During Period, Shares, New Issues Title of 12(b) Security Title of 12(b) Security Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Earnout period, threshold trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Trading Days Warrants and Rights Note Disclosure [Abstract] Share reserve increase, number of years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Share-Based Compensation Arrangement by Share-Based Payment Award, Automatic Increase Per Year, Number of Years Asset Acquisition [Line Items] Asset Acquisition [Line Items] Class of warrant or right, number of securities called by each warrant or right (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Outstanding warrant liabilities Derivative Liability Deemed dividend Preferred Stock, Convertible, Down Round Feature, Increase (Decrease) in Equity, Amount Royalties as a percentage of sales, over threshold amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Asset Acquisition, Royalty Percentage, Over Threshold Amount Automatic conversion, anniversary Preferred Stock, Automatic Conversion, Period Preferred Stock, Automatic Conversion, Period Income Tax Disclosure [Abstract] Consideration received, potential increased amount Sale of Stock, Consideration Received on Transaction, Potential Increased Amount Sale of Stock, Consideration Received on Transaction, Potential Increased Amount Share-Based Payment Arrangement [Abstract] Issuance of common stock upon closing of the Business Combination (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Entity Tax Identification Number Entity Tax Identification Number Maximum aggregate milestone payments per development milestone Asset Acquisition, Maximum Milestone Amount Asset Acquisition, Maximum Milestone Amount Assumption of warrants to purchase common stock in connection with the Business Combination Adjustments to Additional Paid in Capital, Warrants Assumed In Reverse Recapitalization Adjustments to Additional Paid in Capital, Warrants Assumed In Reverse Recapitalization Inventory, net Inventory, net Inventory, Net Warrant exercise period Class Of Warrant Or Right, Days From Which Warrant Or Rights Become Exercisable Class Of Warrant Or Right, Days From Which Warrant Or Rights Become Exercisable Proceeds from private placement Proceeds from Issuance of Private Placement Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Black-Scholes Model Black-Scholes Model [Member] Black-Scholes Model Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Supplemental disclosure of noncash items: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Inventory Disclosure [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Preferred stock available for future issuance (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Commitments and Contingencies Disclosure [Abstract] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Strike price (in dollars per share) Class of Warrant or Right, Strike Price of Warrants or Rights Class of Warrant or Right, Strike Price of Warrants or Rights Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Dynavax Technologies Dynavax Technologies [Member] Dynavax Technologies Entity Address, State or Province Entity Address, State or Province Counterparty Name [Axis] Counterparty Name [Axis] Purchase agreement, exchange cap Purchase Agreement, Exchange Cap Purchase Agreement, Exchange Cap Warrant and Tranche Liabilities / Contingent Earnout Liability Derivatives, Policy [Policy Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Transaction costs incurred Reverse Recapitalization, Transaction Costs Incurred Reverse Recapitalization, Transaction Costs Incurred Balances, beginning of period (in shares) Balances, end of period (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Concentration of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Summary of Components of Inventory Schedule of Inventory, Current [Table Text Block] Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Issuances (Settlements) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) Derivative liability, noncurrent MTAC warrants Derivative Liability, Noncurrent Effective federal tax rate Effective Income Tax Rate Reconciliation, Percent Measurement Input Type [Domain] Measurement Input Type [Domain] Retirements / Conversions Temporary Equity, Value, Conversion Of Convertible Securities Temporary Equity, Value, Conversion Of Convertible Securities Total liabilities Liabilities Asset Acquisition [Axis] Asset Acquisition [Axis] Deemed dividend related to Series B-2 preferred stock down round provision Deemed dividend to preferred stockholders Preferred Stock, Convertible, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount Class of Warrant or Right [Roll Forward] Class of Warrant or Right [Roll Forward] Class of Warrant or Right Accrued bonus Accrued Bonuses, Current Plan Name [Axis] Plan Name [Axis] Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Number of reportable segments Number of Reportable Segments Stock options exercise price, percentage of fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Exercise Price, Granted, Percent Share-Based Compensation Arrangement by Share-Based Payment Award, Exercise Price, Granted, Percent Earnings Per Share [Abstract] Earnings Per Share [Abstract] Purchase agreement period Standby Equity Purchase Agreement, Term Standby Equity Purchase Agreement, Term Sales and marketing Selling and Marketing Expense Common stock, $0.0001 par value per share. Authorized 400,000,000 and 30,898,162 shares at September 30, 2023, and December 31, 2022, respectively; issued and outstanding, 26,316,681 and 347,926 shares at September 30, 2023, and December 31, 2022, respectively Common Stock, Value, Issued Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] General and administrative General and Administrative Expense Warrants repurchased (in shares) Class Of Warrant Or Right, Number Of Warrants Repurchased Class Of Warrant Or Right, Number Of Warrants Repurchased Organization, Consolidation and Presentation of Financial Statements [Abstract] Segment Reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Preferred stock Preferred Stock [Member] Payments on finance lease liabilities Finance Lease, Principal Payments Other expense, net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Conversion price, second automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Preferred Stock, Conversion Price, Automatic Reset Duration, Second Reset Earnout shares vesting percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Vesting Percentage Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Trade payables Accounts Payable, Trade, Current Estimated dividend yield Expected dividends Measurement Input, Expected Dividend Rate [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Warrants outstanding (in shares) Warrants outstanding, beginning balance (in shares) Class of Warrant or Right, Outstanding Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Proceeds from the issuance of preferred stock Proceeds from Issuance of Preferred Stock and Preference Stock RSU weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Beginning balance (in shares) Ending balance (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Accounts Receivable Accounts Receivable [Policy Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Accrued liabilities Other Accrued Liabilities, Current Outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Outstanding Accrued payroll Accrued Salaries, Current Transfer of warrant liability to preferred stock upon exercise of warrants Class of Warrant or Right, Transfer of Warrant to Preferred Stock Class of Warrant or Right, Transfer of Warrant to Preferred Stock Nature of Business Nature of Operations [Text Block] Royalties, sales threshold amount Asset Acquisition, Royalties, Sales Threshold Amount Asset Acquisition, Royalties, Sales Threshold Amount Statement of Financial Position [Abstract] Entity Information [Line Items] Entity Information [Line Items] Proceeds from exercise of preferred stock warrants Proceeds from Warrant Exercises Business Combination and Asset Acquisition [Abstract] Total stockholders’ equity (deficit) Balance, beginning of period Balance, end of period Equity, Attributable to Parent Purchase agreement, number of trading days used for measurement of market price Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Common Stock, Share Price, Market Price, Number Of Consecutive Trading Days Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Cash paid for intellectual property and licenses Payments to Acquire Intangible Assets Common stock warrants Common Stock Warrant [Member] Common Stock Warrant Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Long-term lease liabilities Lease Liability, Noncurrent Lease Liability, Noncurrent Entity Emerging Growth Company Entity Emerging Growth Company Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Stock converted, reverse recapitalization (in shares) Stock Converted, Reverse Recapitalization Stock Converted, Reverse Recapitalization Antidilutive Securities [Axis] Antidilutive Securities [Axis] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Series B-2 preferred stock exercise price per share Measurement Input, Exercise Share Price [Member] Measurement Input, Exercise Share Price Class of warrant or right, threshold number of days for warrants to be transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Class of Warrant or Right, Threshold Number of Days for Warrants to be Transferable Common stock, $0.0001 par value Common stock Common Stock [Member] Proceeds from the issuance of preferred stock Proceeds from Issuance of Convertible Preferred Stock City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Net Loss per Share Earnings Per Share [Text Block] Summary of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Tranche Four Derivative Instrument, Period Four [Member] Derivative Instrument, Period Four Accrued vacation Accrued Vacation, Current Minimum Minimum [Member] Property and equipment, net Property, Plant and Equipment, Net Business Combination Reverse Recapitalization Disclosure [Text Block] Reverse Recapitalization Disclosure Schedule of Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Series B-3 Warrants exercise price per share Measurement Input, Exercise Price [Member] ROU assets Increase (Decrease) in Operating Lease Liability Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Contingent earnout liability recognized upon closing of the Business Combination Adjustments To Additional Paid In Capital, Recognition Of Derivative Instrument, Contingent Consideration Liability Adjustments To Additional Paid In Capital, Recognition Of Derivative Instrument, Contingent Consideration Liability Liabilities Liabilities [Abstract] Change in Unrealized (Gains) Losses Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) Increase in net loss per common share, deemed dividend (in dollars per share) Income (Loss) from Preferred Stock, Convertible, Down Round Feature, Per Basic Share Income (Loss) from Preferred Stock, Convertible, Down Round Feature, Per Basic Share Warrant repurchase program, authorized amount Class Of Warrant Or Right, Repurchase Program, Authorized Amount Class Of Warrant Or Right, Repurchase Program, Authorized Amount Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Final net exercise Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Series B-3 Series B-3 Convertible Preferred Stock [Member] Series B-3 Convertible Preferred Stock Accumulated deficit Retained Earnings [Member] Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Other assets Other Assets, Noncurrent Milestone payments to Dynavax Gain (Loss) on Milestone Payment for Asset Acquistion Gain (Loss) on Milestone Payment for Asset Acquistion Net loss per share, basic (in dollars per share) Earnings Per Share, Basic Right-of-use assets Operating Lease, Right-of-Use Asset Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Purchase agreement, sales price, percentage of market price Share Price As Percentage Of Market Price Commencing On Advance Notice Date Share Price As Percentage Of Market Price Commencing On Advance Notice Date Sale of Stock [Domain] Sale of Stock [Domain] Public warrants, term Warrants and Rights Outstanding, Term Warrants to purchase Series B-3 preferred stock (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Percentage of shares committed Preferred Stock, Percentage of Shares Committed Preferred Stock, Percentage of Shares Committed Entity Address, City or Town Entity Address, City or Town Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Document Transition Report Document Transition Report Commercial Milestone, First Commercial Sale of Product Commercial Milestone, First Commercial Sale of Product [Member] Commercial Milestone, First Commercial Sale of Product Common stock, shares authorized (in shares) Common Stock, Shares Authorized Derivative liability, measurement input Derivative Liability, Measurement Input Tranche [Axis] Tranche [Axis] Tranche Document Information [Table] Document Information [Table] Refundable prepayments for Series B-2 preferred stock Proceeds From Refundable Prepayments for Preferred Stock Proceeds From Refundable Prepayments for Preferred Stock Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Tranche and warrant liability Tranche and Warrant Liability [Member] Tranche and Warrant Liability Derivative Instrument [Axis] Derivative Instrument [Axis] Enterprise value Reverse Recapitalization, Stock Value, If-Converted Amount Enterprise Value Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Liability Class [Axis] Liability Class [Axis] Measurement Input Type [Axis] Measurement Input Type [Axis] Additional paid-in capital Additional Paid in Capital Derivative instrument, contingent consideration, liability, earnout period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Derivative Instrument, Contingent Consideration, Liability, Earnout Period Issuance of common stock upon closing the Business Combination, net of expenses Stock Issued During Period, Value, Reverse Recapitalization Stock Issued During Period, Value, Reverse Recapitalization Subsequent Event Type [Axis] Subsequent Event Type [Axis] Cash proceeds from the exercise of stock options Proceeds from Stock Options Exercised Warrant redemption condition, share price (in dollars per share) Class Of Warrant Or Right, Conversion Stock Price Threshold Class Of Warrant Or Right, Conversion Stock Price Threshold Series B-3 Warrant liabilities Series B-3 Warrants Derivative Financial Instruments, Series B-3 Warrant Liability [Member] Derivative Financial Instruments, Series B-3 Warrant Liability Series A-1 Series A-1 Convertible Preferred Stock [Member] Series A-1 Convertible Preferred Stock Convertible notes and warrants Convertible Notes and Warrants [Member] Convertible Notes and Warrants Closing price (in dollars per share) Share Price 2009 Plan 2009 Plan [Member] 2009 Plan Derivative Instrument, Period [Axis] Derivative Instrument, Period [Axis] Derivative Instrument, Period Schedule of Convertible Preferred Stock Temporary Equity [Table Text Block] Retirements/Conversion (in shares) Class of Warrant Or Right, Conversion Of Convertible Securities Class of Warrant Or Right, Conversion Of Convertible Securities Entity Registrant Name Entity Registrant Name Issuances (in shares) Class Of Warrant Or Right Outstanding, Warrants Issued During Period, New Issues Class Of Warrant Or Right Outstanding, Warrants Issued During Period, New Issues Series A-2 Series A-2 Convertible Preferred Stock [Member] Series A-2 Convertible Preferred Stock Loss on equity issuance Loss on equity issuance Gain (Loss) on Equity Issuance Gain (Loss) on Equity Issuance Public Warrants Public Warrants [Member] Public Warrants Document Period End Date Document Period End Date Sale of stock, authorized amount Sale Of Stock, Authorized Amount, Value Sale Of Stock, Authorized Amount, Value Preferred stock, dividend rate, percentage Preferred Stock, Dividend Rate, Percentage Preferred Stock Preferred Stock [Text Block] Valuation, Reverse Recapitalization Approach, Enterprise Value Valuation, Reverse Recapitalization Approach, Enterprise Value [Member] Valuation, Reverse Recapitalization Approach, Enterprise Value Sales milestone Asset Acquisition, Sales Milestone Asset Acquisition, Sales Milestone Milestone amount Asset Acquisition, Milestone, Amount Asset Acquisition, Milestone, Amount Entity Central Index Key Entity Central Index Key Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Gain (loss) on derivatives Change in fair value of derivative liability Loss on equity issuance Derivative, Gain (Loss) on Derivative, Net Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment Convertible preferred stock, shares authorized (in shares) Temporary Equity, Shares Authorized Income tax expense Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Transaction costs paid from proceeds Reverse Recapitalization, Transaction Costs Paid Reverse Recapitalization, Transaction Costs Paid Financial Instruments Fair Value Disclosures [Text Block] Preferred stock warrants Preferred Stock Warrant [Member] Preferred Stock Warrant Contingent earnout liability Derivative Instrument, Contingent Earnout Liability [Member] Derivative Instrument, Contingent Earnout Liability Number of operating segments Number of Operating Segments Cash and Cash Equivalents [Abstract] Tranche One Derivative Instrument, Period One [Member] Derivative Instrument, Period One Assumption of preferred stock in connection with the Business Combination Issuance of stock Stock Issued During Period, Value, New Issues Stockholders’ equity (deficit): Equity [Abstract] Inventory Inventory Disclosure [Text Block] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Undeclared dividends on Series A preferred stock Undeclared dividends Preferred Stock Dividends, Income Statement Impact Conversion price (in dollars per share) Preferred Stock, Redemption Price Per Share Amendment Flag Amendment Flag Earnout shares vesting requirement, weighted average price per share (in dollars per share) Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Stock Price Trigger Convertible preferred stock, shares outstanding (in shares) Temporary Equity, Shares Outstanding Legal Entity [Axis] Legal Entity [Axis] Number of trading days, VWAP Preferred Stock, Number of Trading Days, Volume Weighted Average Price Preferred Stock, Number of Trading Days, Volume Weighted Average Price Series B-2, B-3 preferred stock fair value per share Series B-3 preferred stock fair value per share Measurement Input, Fair Value Share Price [Member] Measurement Input, Fair Value Share Price 2023 Plan 2023 Plan [Member] 2023 Plan Commercial Milestone, $250,000 Annual Sales Commercial Milestone, $250,000 Annual Sales [Member] Commercial Milestone, $250,000 Annual Sales Commercial Milestone Commercial Milestone [Member] Commercial Milestone Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Conversion price, first automatic reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Preferred Stock, Conversion Price, Automatic Reset Duration, First Reset Series A-6 Series A-6 Convertible Preferred Stock [Member] Series A-6 Convertible Preferred Stock Convertible preferred stock, shares issued (in shares) Temporary Equity, Shares Issued Purchase agreement, ownership limitation Purchase Agreement, Ownership Limitation Purchase Agreement, Ownership Limitation Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Purchase agreement, number of days used for measurement of average daily trading volume Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Common Stock, Share Price, Average Daily Volume, Number Of Trading Days Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Investments in money market funds Money Market Funds, at Carrying Value Reverse Recapitalization [Abstract] Reverse Recapitalization Commercial Milestone, $500,000 Annual Sales Commercial Milestone, $500,000 Annual Sales [Member] Commercial Milestone, $500,000 Annual Sales Operating expenses: Operating Expenses [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Additional paid-in capital Additional Paid-in Capital [Member] Payments for milestone Payments for Asset Acquisition, Milestone Amount Payments for Asset Acquisition, Milestone Amount Total assets Assets Fair value of warrant liability Proceeds from Issuance of Warrants Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Commercial Milestone Type [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Derivative Instrument, Period [Domain] Series A Convertible Preferred Stock Series A Convertible Preferred Stock [Member] Series A Convertible Preferred Stock Short-term lease liabilities Lease Liability, Current Lease Liability, Current Commercial Milestone Type [Axis] Commercial Milestone Type [Axis] Commercial Milestone Type Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Tranche Three Tranche Three [Member] Tranche Three Upfront payment Asset Acquisition, Consideration Transferred Cash, cash equivalents and restricted cash Cash and Cash Equivalents Disclosure [Text Block] Earnout period, threshold consecutive trading days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Derivative Instrument, Contingent Consideration, Liability, Earnout Period, Threshold Consecutive Trading Days Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Tranche Three Derivative Instrument, Period Three [Member] Derivative Instrument, Period Three Equity Component [Domain] Equity Component [Domain] Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) Proceeds from Business Combination Proceeds from business combination Proceeds From Reverse Recapitalization Proceeds From Reverse Recapitalization Statement [Line Items] Statement [Line Items] Conversion of redeemable convertible preferred stock into common stock in connection with the Business Combination Stock Issued During Period, Value, Conversion of Convertible Securities Standby Equity Purchase Agreement Standby Equity Purchase Agreement [Member] Standby Equity Purchase Agreement Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Number of commercial milestones Asset Acquisition, Number of Commercial Milestones Asset Acquisition, Number of Commercial Milestones Series B-2 tranche liabilities Derivative Financial Instruments, Tranche Liability [Member] Derivative Financial Instruments, Tranche Liability Gain on change in fair value Derivative, Gain on Derivative Warrants Warrants Liabilities [Text Block] Warrants Liabilities Milestone payments to Dynavax Payments for Assets Acquisition Milestone Payments for Assets Acquisition Milestone